During the past decade, Hospital Regional Hans Dieter Schmidt conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Regional Hans Dieter Schmidt" #1 sponsor was "Hospital Israelita Albert Einstein" with 2 trials, followed by "Brazilian Clinical Research Institute" with 1 trials sponsored, "Hospital Alemão Oswaldo Cruz" with 1 trials sponsored, "Hospital Dona Helena" with 1 trials sponsored and "Saint Luke's Health System" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Regional Hans Dieter Schmidt" #1 collaborator was "Brazilian Research In Intensive Care Network" with 3 trials as a collaborator, "Hospital Sirio-Libanes" with 3 trials as a collaborator, "Hospital do Coracao" with 3 trials as a collaborator, "Hospital Israelita Albert Einstein" with 2 trials as a collaborator and "Hospital Moinhos de Vento" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Regional Hans Dieter Schmidt" are "COVID-19" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronavirus Infection" (1 trials), "Coronavirus Infections" (1 trials) and "Obesity Class III" (1 trials). Many other conditions were trialed in "Hospital Regional Hans Dieter Schmidt" in a lesser frequency.

Most popular intervention types in "Hospital Regional Hans Dieter Schmidt" are "Drug" (4 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Hydroxychloroquine" (2 trials), "Dapagliflozin 10 milligram (mg)" (1 trials), "Double Dose Quadrivalent Influenza Vaccine" (1 trials) and "Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Regional Hans Dieter Schmidt" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Regional Hans Dieter Schmidt". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Regional Hans Dieter Schmidt, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Regional Hans Dieter Schmidt, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".